Join the club for FREE to access the whole archive and other member benefits.

Eli Lilly and Company

American pharmaceutical company

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Visit website: https://www.lilly.com/

 elilillyandco

 eli-lilly-and-company

 lillypad

 EliLillyandCompany

Details last updated 30-Apr-2020

Eli Lilly and Company Creations

Humalog

Type of insulin used to treat type I and type II diabetes.

People at Eli Lilly and Company

Andrew Adams

Co-director at Lilly Institutes for Genetic Medicine and SVP Neurodegeneration Research

Natalia Novac

Senior Director Emerging Technologies and Innovation at Eli Lilly and Company.

Daniel Skovronsky

Senior Vice President and Chief Scientific Officer, Eli Lilly and Company

Mark Mintun

Vice-President of Pain and Neurodegeneration, Eli Lilly and Company

Eli Lilly and Company News

The future of longevity: investing in the next biotech revolution

The future of longevity: investing in the next biotech revolution

The Motley Fool - 13-Aug-2024

How lifespan-extending drugs could shape the next biotech boom

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

pharmaphorum - 08-Jan-2024

Their AlphaFold engine models proteins could lead to faster and more effective treatments

Isomorphic labs teams up with pharma giants for AI-driven drug discovery

Isomorphic labs teams up with pharma giants for AI-driven drug discovery

TechCrunch - 07-Jan-2024

Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments

Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership

Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership

Longevity Technology - 21-Dec-2023

Fauna's AI platform explores animal data to unlock breakthroughs in weight management

Donanemab slows Alzheimer’s disease in trial, but with serious side effects

Donanemab slows Alzheimer’s disease in trial, but with serious side effects

New Scientist - 18-Jul-2023

New Alzheimer's drug benefits early-stage patients; concern remain about affordability and serious risks

Longevity Vision Fund joins Series B funding for Sigilon Therapeutics

Longevity Vision Fund joins Series B funding for Sigilon Therapeutics

Longevity Vision Fund - 20-Apr-2020

To support human clinical trial of novel encapsulated cell therapy for hemophilia A

Alector raises 133 million to tackle neurodegenerative diseases

Alector raises 133 million to tackle neurodegenerative diseases

Biospace - 25-Jul-2018

Advancing immune-based therapies for alzheimer’s and dementia

Personalised medicine and the ‘batch of you’

Personalised medicine and the ‘batch of you’

Silicon Republic - 30-Sep-2017

FDA approved in 2017, Kymriah is entirely customised to the individual patient. Eight of the top...

Digital health pharma news from Q4 2016

Digital health pharma news from Q4 2016

MobiHealthNews - 13-Jan-2017

Investment in digital tools to enhance data collection in clinical trials. Litmus Health using w...